PVSRIPO in Combination With Nivolumab in Melanoma

NCT04125719 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped resubmission planned

Conditions

Melanoma

Interventions

BIOLOGICAL: PVSRIPO
DRUG: Nivolumab

Sponsor

Darell Bigner

Collaborators

[object Object]
[object Object]
[object Object]